Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CPMP recommends European approval of Visudyne for wet AMD

April 19, 2000

FDA approves Visudyne therapy for treatment of AMD

April 13, 2000

Interferon alfa-2b offers protection from eye involvement in Behcet's disease

April 13, 2000

New ocular antibiotic enters the pipeline at InSite Vision

April 12, 2000

Gilead licenses NX-1838, a new AMD treatment, to EyeTech

April 10, 2000

QLT and Ciba Vision report positive Visudyne clinical results

April 3, 2000

Neurocrine Biosciences awarded NIH grant for retinal ischemia research

April 3, 2000

Visudyne T-IND program expanded

March 20, 2000

InSite Vision's batimastat eyedrops show antiangiogenic activity

March 20, 2000

Ciba Vision seeks approval of Rescula on two continents for treatment of glaucoma

March 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...